DCR-PHXC
Showing 176 - 183 of 183
Advanced Stage Non Small Cell Lung Cancer Trial in Guangzhou (Erlotinib 100mg qd, Gefitinib 250mg qd)
Unknown status
- Advanced Stage Non Small Cell Lung Cancer
- Erlotinib 100mg qd
- Gefitinib 250mg qd
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Cancer Center of Sun Yat-Sen Uni
Jul 1, 2015
Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic
Completed
- Dacryocystitis
-
Wenzhou, Zhejiang, ChinaWenzhou Medical College
Feb 12, 2014
Renal Cell Carcinoma Trial in Mannheim (Sunitinib (Sutent), Sorafenib (Nexavar))
Completed
- Renal Cell Carcinoma
- Sunitinib (Sutent)
- Sorafenib (Nexavar)
-
Mannheim, Baden-Wuerttemberg, GermanyUrologische Klinik
Apr 22, 2014
NSCLC Trial in Guangzhou (Gefitinib 500mg/Gefitinib 250mg)
Completed
- Non-small Cell Lung Cancer
- Gefitinib 500mg/Gefitinib 250mg
-
Guangzhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University
Dec 8, 2013
Head Neck Cancer Squamous Cell Metastatic, Head Neck Cancer Squamous Cell Recurrent Trial in Seoul (BKM120)
Unknown status
- Head Neck Cancer Squamous Cell Metastatic
- Head Neck Cancer Squamous Cell Recurrent
-
Seoul, Korea, Republic ofSeverance Hospital
Oct 4, 2012
Nasolacrimal Tract Obstruction Trial in Afula (Tranexamic acid, saline solution)
Unknown status
- Nasolacrimal Tract Obstruction
- Tranexamic acid
- saline solution
-
Afula, IsraelDept. of Ophthalmology, HaEmek medical center
Oct 14, 2010
Colorectal Tumors Trial in Laval (OXALIPLATIN (SR96669), 5-FLUOROURACIL (5-FU), LEUCOVORIN (LV))
Withdrawn
- Colorectal Neoplasms
- OXALIPLATIN (SR96669)
- +3 more
-
Laval, CanadaSanofi-Aventis Administrative Office
Dec 21, 2009